NIVAHF is an investigational device designed to monitor the venous waveform, a novel physiologic signal, in heart failure patients
June 15, 2021
VoluMetrix's NIVA|HF for Heart Failure Patients Designated as Breakthrough Device by U.S. FDA
June 15, 2021 — VoluMetrix, a Nashville-based biotech startup dedicated to creating a new wave of solutions for vital…
Read More
A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs.
June 15, 2021
Cardiac MRI Effective in Detecting Asymptomatic, Symptomatic Myocarditis in Athletes
June 15, 2021 — A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of…
Read More
Rensselaer algorithm can identify risk of cardiovascular disease using lung cancer scan #CT
June 14, 2021
Deep Learning Enables Dual Screening for Cancer and Cardiovascular Disease
June 14, 2021 — Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly…
Read More
Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.
June 14, 2021
Deep Learning with SPECT Accurately Predicts Major Adverse Cardiac Events
June 14, 2021 — An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac…
Read More
Image from the announcement of the Neal award winner of best technical content for DAIC's coverage of COVID-10 related to cardiology at the Neal virtual award ceremony June 9.
June 10, 2021
DAIC Wins Neal Award for Best Technical Coverage of COVID-19
June 10, 2021 — Diagnostic and Interventional Cardiology (DAIC) magazine has won a prestigious Jesse H. Neal Award for…
Read More
GE is integrating artificial intelligence into most of its imaging and information technology software. AI can aid fast critical care decision making. Above left is the vScan Air wireless point-of-care ultrasound system. It integrates AI for immediate, automated assessment of a patient's ejection fraction, right.
June 10, 2021
AI Collaboration is Key to Unlock its Power in Cardiac Care
The digital transformation of healthcare is underway, but it will advance further and faster if key stakeholders work…
Read More
AI Med will present its Virtual Clinical Series: Imaging Built by Clinicians, for Clinicians, June 29-30, 2021.
June 09, 2021
AI Med Virtual Conference Focuses on AI in Imaging-focused Subspecialties
June 9, 2021 — AI Med will present its Virtual Clinical Series: Imaging Built by Clinicians, for Clinicians, June 29-30…
Read More
Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.
By Dave Fornell, Editor
June 08, 2021
Key Cardiology Technology Takeaways at ACC 2021
Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021…
Read More
Two years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at ACC.21.
June 07, 2021
SAFE-PAD Study Shows No Safety Issues With Paclitaxel-coated Devices In Peripheral Artery Disease
June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery…
Read More
The 30-day outcomes from the TRISCEND study of the transfemoral Evoque tricuspid valve replacement system demonstrated technical feasibility and an acceptable safety profile, along with improvements in tricuspid regurgitation (TR) and symptoms in patients with clinically significant TR.
June 07, 2021
Edwards LifeSciences Reports Positive Clinical Updates on its Transcatheter Mitral and Tricuspid Valves
June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral…
Read More
Rates of burnout pre- and peak COVID-19 pandemic increased across all members of the cardiology care team and was particularly striking among cardiovascular team members, which researchers said may be because they were more likely at the bedside as patients were dying. Among all cardiovascular clinicians – cardiologists, physician assistants, nurse practitioners, nurses, pharmacists and imaging technologists – half provided direct care to patients with COVID-19. #COVID19 #ACCCOVID
June 07, 2021
Burnout Rate Doubles For Cardiology Clinicians Amid COVID-19 Pandemic
June 7, 2021 — The COVID-19 pandemic has taken a significant toll on cardiovascular clinicians, many of whom provide…
Read More
The Aortix intra-aortic axial flow pump offers hemodynamic support to relieve some of the heart’s workload, allowing the heart to recover while more effectively pushing blood flow to the kidneys.
June 07, 2021
Cardiologists at Henry Ford Are First in U.S. to Implant Aortix Heart Pump to Treat Heart Failure
June 7, 2021 – Cardiologists at Henry Ford Hospital are first in the U.S. and second in the world to implant a…
Read More
Avicenna.AI announces the introduction of Cina Chest, including AI tools for detection and emergency triage of pulmonary embolism and aortic dissection.
June 07, 2021
AI Triage Solution for PE and Aortic Dissection Receives FDA Clearance and CE Mark
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced that it has received certification in the United…
Read More
U.S. positive COVID test case data for 2020 through June 3, 2021, It shows four clear waves of spikes in U.S. COVID cases. Most of these appeared to be partly fueled by people gathering during the July 4, Halloween, Thanksgiving, Christmas, New Year's, Valentine's Day, and easter holidays. Source: John Hopkins University
By Dave Fornell, Editor
June 04, 2021
COVID Testing Data Shows Impact of Vaccinations and Holidays on New Cases
Vaccinations appear to to be helping reduce COVID-19 virus positive case numbers, and a review of the U.S. COVID…
Read More
GE Healthcare had integrated artificial intelligence algorithms into many of its device technologies. Recently the vendor introduced AI-enabled real-time automated ejection fraction measurements on its Venue Go point of care ultrasound system.
June 03, 2021
GE Healthcare and the ACC Join Forces to Advance AI in Cardiac Care
June 3, 2020 — GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and…
Read More
MRI scan of heart damaged by COVID, which can cause myocarditis, infarction and/or ischemia. Blue means reduced blood flow, orange is good blood flow. In this figure the inferior part of the heart shows dark blue, so the myocardial blood flow is very reduced. The angiogram shows the coronary artery which supplies the blood to this part of the heart is occluded. The three colored MRI images show different slices of the heart — the basal mid and apical slices. Image courtesy of European Heart Journal
June 03, 2021
IMAGE GALLERY: How COVID-19 Appears on Medical Imaging
DAIC's sister radiology magazine Imaging Technology News (ITN) has created a photo gallery that shows a variety of…
Read More
American Society of Nuclear Cardiology (ASNC) offers 5 Strategies for Improving Your Nuclear Cardiology Lab in 2021
By Staff of the American Society of Nuclear Cardiology (ASNC)
June 02, 2021
5 Strategies for Improving Your Nuclear Cardiology Lab in 2021
A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how…
Read More
The HLT, Bracco, Meridian II TAVR Valve System.
Dave Fornell, Editor
June 02, 2021
Bracco Moving Forward With HLT Meridian TAVR Valve
June 2, 2021 — The startup company HLT is a part of the Bracco Group, which is developing a new transcatheter aortic…
Read More
Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.
June 02, 2021
Implicity Signs U.S. Distribution Agreement With MicroPort CRM to Expand Remote Monitoring of Various Implanted Cardiac Devices
June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions,…
Read More
The LivaNova Percelval sutureless aortic valve and Solo Smart surgical aortic valve are part of heart valve portfolio the company sold off June 1 to Gyrus Capital and Corcym..
June 02, 2021
LivaNova Sells Heart Valve Business to Gyrus Capital
June 2, 2021 – LivaNova announced June 1 it successfully completed the initial closing of the divestiture of its heart…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now